• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • WORLD EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • WORLD EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Emerging Technology Market
    Emerging Technology News
    Emerging Technology Stocks
    • Emerging Technology Market
    • Emerging Technology News
    • Emerging Technology Stocks
    graphene investing

    Completion of the Transaction with Group NanoXplore

    Written by Melissa Shaw
    |
    Aug. 30, 2017 08:41AM PST

    NanoXplore (Formerly Graniz Mondal) (TSX VENTURE:GRA.H) (the “Corporation”) is pleased to announce the completion of the previously announced three-cornered amalgamation involving Graniz Mondal, Group NanoXplore and 9363-0770 Québec which constituted a reverse takeover of Graniz Mondal under the policies of the TSX Venture Exchange (the “Transaction”). Pursuant to the Transaction, the Corporation consolidated its share …

    NanoXplore (Formerly Graniz Mondal) (TSX VENTURE:GRA.H) (the “Corporation”) is pleased to announce the completion of the previously announced three-cornered amalgamation involving Graniz Mondal, Group NanoXplore and 9363-0770 Québec which constituted a reverse takeover of Graniz Mondal under the policies of the TSX Venture Exchange (the “Transaction”).
    Pursuant to the Transaction, the Corporation consolidated its share capital on a 15:1 basis and changed its name to “NanoXplore”.
    As previously announced, Group NanoXplore completed on August 2, 2017 a private placement of subscription receipts for gross proceeds of approximately $9.7 million (the “Private Placement”). In connection with the Transaction, each subscription receipt was ultimately converted into one common share and one-half common share purchase warrant of the Corporation.
    About NanoXplore

    NanoXplore is a graphene company, a manufacturer and supplier of high volume graphene powder for use in industrial markets as well as standard and custom graphene enhanced thermoplastic products to many customers in transportation, packaging, electronics and other industrial sectors.

    Click here to read the full text release. 

    private placementgraphene companygraphene investing
    The Conversation (0)

    Go Deeper

    AI Powered

    NanoXplore Reports First Quarter 2023 Results and Unveils Its 5-year Strategic Plan

    NanoXplore Unveils a Large-Scale Dry Process for Manufacturing of Graphene: An Improvement for Cost Competitiveness and Scalability

    Latest News

    Miivo Expands Customer Base Across Healthcare, Legal, and Hospitality Sectors

    Tim Cook to become Apple Executive Chairman; John Ternus to become Apple CEO

    Johny Srouji named Apple's Chief Hardware Officer

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
      • Electric Vehicles
    • Agriculture
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Energy
      • Uranium
      • Oil and Gas
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Robotics
      • Crypto
      • Cleantech
    Life Science
      • Biotech
      • Cannabis
      • Pharmaceuticals

    Featured Emerging Technology Investing Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES